Pilot for Junior Investigators in Basic and
Project Award Amount $30,000
$37,500 if funded by the Cancer Center-Cancer Center Support Grant (CC-CCSG)
$25,000 if funded by the Alzheimer Disease Research Center (ADRC)
These pilot projects are intended to support a wide range of biomedical research, including fundamental basic science, clinical/translational science, health policy and social science, and population science.
Pilot projects are for one year and not renewable. (Some funding agencies allow for no-cost extensions. This will be clarified in the Award Letter.) All funding agencies require progress reports if an award is received. The number and timing of those reports varies between the agencies. Detailed information about this will appear in the respective funding agencies Award Letter.
Assistant Professors in the early phase of their career and Instructors in all series, including adjunct and professional research may apply. Exceptions must be fully justified.
Note - Proposals in the Alzheimer's disease area may be submitted by pre-faculty Fellows. Please note that the ADRC is the only funding agency that will fund applications from fellows.
- For grants funded by the Cancer Center-MZHF applicants must be Physician-Scientists, Cancer Center Members or be sponsored by a Cancer Center Member. Please address this in any cancer-related proposal.
- For grants funded by the Cancer Center-CCSG applicants must be Cancer Center Members or Associate Members. Please address this in any cancer-related proposal.
Who's Not Eligible:
Fellows are generally not eligible with the only exception of the ADRC. Specialists are not eligible.
Designation of Research Mentor
All pilot award applications from individuals at the Assistant Professor level or below require the designation of a faculty mentor. This should be an individual who has primary responsibility for overseeing the research career development of the applicant.
Criteria for Review/Evaluation of Applications
Projects will be evaluated based on the quality of the proposed scientific investigation, the potential of the proposal to lead to a fully funded independent research grant, and the quality and potential of the applicant and the research team.
More on individual funding agencies
(Please note, this is provided for informational purposes only since the review process is centralized).
- Academic Senate grants are made available in part through endowment funds allocated to specific areas of research. In addition to general funds, the Committee on Research awards money from endowment funds for these specific areas of research:
- Heart disease
- Parkinson's disease
- Heart disease, cancer, vascular or circulatory disorders, and epilepsy
- Eye diseases
- Stomach ailments
Note: the above categories apply to both research on the specified disease and related areas of focus. For example, "stomach ailments research" can include stomach ulcers research and research into diabetes focusing on stomach disorders or ailments.
- The Alzheimer's Disease Research Center (ADRC) at the UCSF Memory and Aging Center is supporting two awards ($25,000 each for one year) for promising pilot projects. This exciting program aims to promote novel dementia-related basic biomedical and patient-oriented research at UCSF. Applications will be evaluated based on their relevance to Alzheimer's disease and related disorders, innovation, and scientific rigor. In April 2004, the UCSF was designated as a national Alzheimer's Disease Research Center (ADRC). The Memory and Aging Center is the central coordinating site for the ADRC. Fellows with proposals in the Alzheimer's disease area are welcome to apply. Please note that the ADRC is the only funding agency that will consider applications from fellows for this pilot. Funded by the NIH, this large collaborative project involves multiple institutions and locations. It is designed to integrate basic science and clinical resources in order to investigate the clinical, molecular, neuropathological and neuroimaging features of Alzheimer's disease (AD), non-AD dementias, and mild cognitive impairment (MCI). The ADRC has two overarching aims:
- To bridge the gap between laboratory and clinical studies in dementia and aging
- To explore the unique and overlapping symptoms seen in various neurodegenerative diseases
- The ADRC uses standardized and novel methods to examine patients and biological specimens, so that new hypotheses can be tested regarding the pathogenesis, diagnosis, and treatment of dementia. The ADRC brings together investigators who are leaders in basic science and clinical research related to dementia
- Cancer Center-MZHF (funded by the Mt. Zion Health Fund) provides seed funding to encourage clinical and clinical translational scientists, especially those at the beginning of their research career or established investigators wishing to embark on a new area of study, to initiate promising new projects in cancer research that may enable them to compete successfully for federal research grants. Targeted areas are innovative pilot, phase I/II therapeutic studies and other projects in clinical, health policy, health services, psychosocial and behavioral research that have direct application to the prevention, diagnosis, and treatment of cancer. Pre-clinical or laboratory correlative studies that demonstrate a direct path to the clinic will also be considered. Applicants must be physician-scientists and a Cancer Center member or be sponsored by a Cancer Center member. Investigators who are proposing basic science and population research projects are eligible for funding through the Academic Senate, REAC, and CTSI-SOS.
- Cancer Center-CCSG (funded by the NCI P30 award) provides seed funding to encourage innovative cancer-related research in a wide range of research areas, including basic science, clinical and translational science, health policy and social science, and population sciences. Priority is given to translational science and to areas that are generally under-represented, such as population sciences. This program supports novel cancer research initiatives which are not currently funded by research grants and which may ultimately lead to new ways of preventing, detecting or treating cancer. Emphasis is placed on innovative projects, and applicants must be a Cancer Center Member or Associate Member.
- CTSI-SOS requires that the proposal meet CTSI criteria of translational science. International research requires prior approval from the NIH which will likely case a delay in the start of the proposed research. All funded research conducted in an international setting must have both UCSF and international institution CHR approval. International subcontracts are not allowed per NIH policy.
Note - For grants currently funded by SOS, K Career Development awardees cannot receive salary support from this award.
- REAC funds pilot projects ranging from basic to clinical and translational. Pilot research should collect data for publication and to acquire successful subsequent funding by other mechanisms. Only School of Medicine faculty qualify for REAC funds.
Emanuela (Emy) Volpe
RAP - Program Manager
|Spring 2013 Cycle
Call for Applications:
January 28, 2013
* * *
February 25, 2013
2:00 pm PST
* * *